Halting the Oxford vaccine trial doesn't mean it's not safe – it shows they're following the right process
COVID-19: Difficult trade-offs in AstraZeneca vaccine development | Science| In-depth reporting on science and technology | DW | 28.10.2020
AstraZeneca aims to go carbon free by 2025—and it'll spend $1B to do it | FiercePharma
AstraZeneca's COVID-19 vaccine shows midphase promise in seniors | FierceBiotech
Oxford and AstraZeneca to resume Covid vaccine trial, Health News, ET HealthWorld
EUR068: Enforcement (No. 2006/857/EC, Case COMP/A.37.507/F3 — AstraZeneca), Decision, 2005
A leading coronavirus vaccine trial is on hold: scientists react
Impact of a five-dimensional framework on R&D productivity at AstraZeneca | Nature Reviews Drug Discovery
AstraZeneca Covid-19 vaccine study is put on hold
AstraZeneca deal to supply EU with 300 million COVID-19 vaccine doses - CGTN
APO Group - Africa Newsroom / Press release | AstraZeneca to partner with UNICEF to help prevent non-communicable diseases among five million young people worldwide
Investments in health systems
AstraZeneca México - Videos | Facebook
COVID-19 clinical MDT experience sharing webcast
AstraZeneca accelerates drug discovery thanks to PELE technology | BSC-CNS
AstraZeneca partners its way to a genomic bounty | Science | AAAS
COVID-19: Difficult trade-offs in AstraZeneca vaccine development | Science| In-depth reporting on science and technology | DW | 28.10.2020
PDF) Lessons learned from the fate of AstraZeneca's drug pipeline: A five-dimensional framework
The COVID vaccine challenges that lie ahead
AstraZeneca COVID-19 vaccine shows average efficiency of 70% - CGTN
AstraZeneca accelerates drug discovery thanks to PELE technology | BSC-CNS
Egypt - AstraZeneca
AstraZeneca-Oxford Coronavirus Vaccine Trials Paused After Unexpected Illness In Volunteer
AstraZeneca's COVID-19 Vaccine Trial Is On Hold Because A Volunteer Became Ill : Coronavirus Updates : NPR
Scientists relieved as coronavirus vaccine trial restarts — but question lack of transparency
